Abstract: A biocompatible soft tissue implant for introduction into a human body includes at least one layer comprising an elastomeric material, and at least one textile fabric arranged on the at least one layer comprising the elastomeric material. The at least one textile fabric forms a surface of the biocompatible soft tissue implant. The at least one textile fabric includes bioresorbable fibers which are embedded at least partially in the at least one layer comprising the elastomeric material.

Abstract: A biocompatible composite material for complete or partial insertion into a human body includes at least one layer comprising an elastomeric material, and at least one textile fabric arranged on the at least one layer comprising the elastomeric material. The at least one textile fabric forms a surface of the biocompatible composite material. The at least one textile fabric includes bioresorbable fibers that are embedded at least partially in the at least one layer comprising the elastomeric material.

Abstract: A medical device in the form of a nonwoven wound dressing includes rotospun fibers including at least one synthetic and bioabsorbable polymer and at least one hydrophilic and/or tissue-adhesive polymer, and a method of producing the medical device including using rotospinning to produce fibers from a fiber raw material including at least one synthetic and bioabsorbable polymer and at least one hydrophilic and/or tissue-adhesive polymer.

Abstract: A nonwoven fabric includes fibers of a fiber raw material including gelatin, the fibers including at least one of an antimicrobially effective substance and an antibiotic, wherein the fibers are produced by rotational spinning.

Abstract: A multi-component fiber includes a first component made of a first fiber raw material and a second component made of a second fiber raw material. The first and second components are combined by rotational spinning so as to form a fiber body.

Abstract: The present invention is directed to novel non-woven fabrics containing growth and differentiation factor proteins. Said fabrics are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues. Furthermore, the invention provides wound dressings, pads or implants comprising the novel non-woven fabrics.

Abstract: The present invention is directed to novel non-woven fabrics containing growth and differentiation factor proteins. Said fabrics are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues. Furthermore, the invention provides wound dressings, pads or implants comprising the novel non-woven fabrics.

Abstract: A medical device in the form of a nonwoven wound dressing includes rotospun fibers including at least one synthetic and bioabsorbable polymer and at least one hydrophilic and/or tissue-adhesive polymer, and a method of producing the medical device including using rotospinning to produce fibers from a fiber raw material including at least one synthetic and bioabsorbable polymer and at least one hydrophilic and/or tissue-adhesive polymer.

Abstract: A fabric sheet, with low-cost production, has high thermal and light stability, is recyclable, has a high mechanical load-bearing capacity, and is elastically compliant, wherein the fabric sheet has a main body composed of at least one ply, wherein the at least one ply contains first fibers comprising a first polymer and second fibers with a second polymer or wherein the at least one ply has one and the same fibers that contain a first and a second polymer, wherein a cold crystallization temperature of the first polymer lies at the softening temperature of the second polymer or below the softening temperature of the second polymer.

Abstract: The present invention is directed to novel non-woven fabrics containing growth and differentiation factor proteins. Said fabrics are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues. Furthermore, the invention provides wound dressings, pads or implants comprising the novel non-woven fabrics.

Abstract: The present invention is directed to novel non-woven fabrics containing growth and differentiation factor proteins. Said fabrics are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues. Furthermore, the invention provides wound dressings, pads or implants comprising the novel non-woven fabrics.

Abstract: The invention relates to a biodegradable fleece containing (i) at least one polymer for inducing primary haemostasis, (ii) at least one non-proteinogenic, low-molecular, water-soluble activator of secondary haemostasis, and (iii) at least one non-proteinogenic, low-molecular, water-soluble inhibitor of fibrinolysis. The invention also relates to a method for producing a biodegradable fleece, in which (i) a fluidised fiber raw material, and additives if applicable, is placed in a container, (ii) the container is made to rotate, (iii) the fluidised fiber raw material is dispensed from the container by means of centrifugal forces, whereby fibers or filaments are formed, and (iv) a biodegradable fleece is produced from the fibers or filaments. The invention also relates to the use of said biodegradable fleece as a local haemostatic agent.

Abstract: The present invention is directed to novel non-woven fabrics containing growth and differentiation factor proteins. Said fabrics are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues. Furthermore, the invention provides wound dressings, pads or implants comprising the novel non-woven fabrics.

Abstract: A multi-component fiber includes a first component made of a first fiber raw material and a second component made of a second fiber raw material. The first and second components are combined by rotational spinning so as to firm a fiber body.

Abstract: In order to provide a non-woven fiber fabric, in particular, in the form of a flat material or as part of a flat material which can be used as a biodegradable material in medicine, in particular, as an implant or carrier material for living cells (tissue engineering) but also a non-woven fiber fabric which can be used in food technology in a variety of applications, in particular, as a preliminary product for foods, a non-woven fiber fabric is provided containing fibers consisting of a gelatin material, wherein the thickness of the fibers is on average 1 to 500 ?m and wherein the non-woven fiber fabric has a plurality of areas, at which two or more fibers merge into one another without any phase boundary.

Abstract: A medical instrument includes a tube, a bioresorbable nonwoven disposed in the tube, and a plunger disposed inside the tube that closes off a first end of the tube. The plunger is movable relative to the tube and slidable inside the tube so as to expel the nonwoven from the tube through actuation of the plunger.

Abstract: A nonwoven fabric includes fibers of a fiber raw material including gelatin, the fibers including at least one of an antimicrobially effective substance and an antibiotic, wherein the fibers are produced by rotational spinning.

Abstract: In order to provide a non-woven fiber fabric, in particular, in the form of a flat material or as part of a flat material which can be used as a biodegradable material in medicine, in particular, as an implant or carrier material for living cells (tissue engineering) but also a non-woven fiber fabric which can be used in food technology in a variety of applications, in particular, as a preliminary product for foods, a non-woven fiber fabric is provided containing fibers consisting of a gelatin material, wherein the thickness of the fibers is on average 1 to 500 ?m and wherein the non-woven fiber fabric has a plurality of areas, at which two or more fibers merge into one another without any phase boundary.

Abstract: A gas diffusion layer, including at least two functional areas (2a, 2b) which are operationally linked to one another, the first area (2a) having a porous structure and the second area (2b) being designed as a stabilization zone, achieves the object of providing a system which implements problem-free operation of a fuel cell while optimizing its efficiency. A system which includes two gas diffusion layers and a method for manufacturing the gas diffusion layer achieve the further cited objects.

Abstract: A three-dimensional moulded planar cable, includes a laminate made from at least one conductor track, bonded between two insulation layers and at least one support layer, connected to each other by an adhesive layer. The cable is applied to a positive moulding tool, brought into shape by the application of heat and/or radiation and/or pressure and fixed in the three-dimensional shape thereof by cooling to below the glass temperature Tg of the adhesive layer or by hardening of the adhesive layer.